Patents by Inventor Douglas Ross Morton, Jr.

Douglas Ross Morton, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 13,14-Dihydro-9.beta.-RGD, compounds
    Patent number: 4122099
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: October 24, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • CIS-4,5-Didehydro-9-deoxy-9,10-didehydro-PGD.sub.1 compounds
    Patent number: 4122098
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: January 3, 1977
    Date of Patent: October 24, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • 13,14-Dihydro-9.beta.-PGD.sub.2 compounds
    Patent number: 4120879
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: October 17, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • 9.beta.-PGD.sub.1 Compounds
    Patent number: 4120880
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: October 17, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • Inter-oxa-9-deoxy-9,10-didehydro-PGD.sub.1 compounds
    Patent number: 4119672
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: October 10, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • Inter-oxa-13,14-dihydro-9.beta.-PGD.sub.1 compounds
    Patent number: 4118415
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: October 3, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • Inter-oxa-13,14-dihydro-9.beta.-PGD.sub.1 compounds
    Patent number: 4117005
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: September 26, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • PGD.sub.2 analogs
    Patent number: 4108878
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: January 3, 1977
    Date of Patent: August 22, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • Cis-13-9-deoxy-9,10-didehydro-PGD.sub.2 compounds
    Patent number: 4094891
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: June 13, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • 3,7-Inter-m-phenylene-4,5,6-trinor-13,14-dihydro-PGD.sub.1 compounds
    Patent number: 4087615
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: May 2, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • Cis-13-PGD.sub.2 compounds
    Patent number: 4086259
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and process for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: April 25, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • 13,14-Dihydro-PGD.sub.2 compounds
    Patent number: 4083859
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: April 11, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • Inter-oxa-13,14-dihydro-PGD.sub.1 compounds
    Patent number: 4083865
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: April 11, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • Cis-13-PGD.sub.1 compounds
    Patent number: 4082784
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: April 4, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • Inter-oxa-PGD.sub.1 compounds
    Patent number: 4082794
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: April 4, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • 13,14-Dihydro-PGD.sub.1, analogs
    Patent number: 4082782
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: April 4, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • 3,7-Inter-m-phenylene-4,5,6-trinor-9B-PGD, compounds
    Patent number: 4070538
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: January 24, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • 3,7-Inter-M-phenylene-4,5,6-trinor-13,14-dihydro-9.beta.-PGD.sub.1 compounds
    Patent number: 4069390
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: January 17, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • 3,7-Inter-m-phenylene-4,5,6-trinor-9-deoxy-9,10-didehydro-PGD.sub.1 compounds
    Patent number: 4069389
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: January 17, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.
  • 3,7-Inter-m-phenylene-4,5,6-trinor-PGD.sub.1 compounds
    Patent number: 4066836
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: December 30, 1976
    Date of Patent: January 3, 1978
    Assignee: The Upjohn Company
    Inventor: Douglas Ross Morton, Jr.